Viewing Study NCT01065558

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-05-18 @ 12:50 AM
Study NCT ID: NCT01065558
Status: COMPLETED
Last Update Posted: 2013-04-18
First Post: 2010-02-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease
Sponsor: Psyadon Pharma
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lesch-Nyhan Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ecopipam View
None Lesch-Nyhan Disease View
None Safety View
None Self-Injurious Behavior View